Treatment outcomes of human bartonellosis: A systematic review and meta-analysis

International Journal of Infectious Diseases

Volumn 17, Issue 10, 2013, Pages

  Prutsky, Gabriela ^a,b   Domecq, Juan Pablo ^a,b   Mori, Laura ^b   Bebko, Serge ^b   Matzumura, Melissa ^b,c   Sabouni, Amar ^a   Shahrour, Anas ^a   Erwin, Patricia J ^a   Boyce, Thomas G ^a   Montori, Victor M ^a,b   Malaga, German ^b   Murad, M Hassan ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

Antibiotic treatment; Bacillary angiomatosis; Bartonella bacilliformis; Bartonella henselae; Bartonella quintana; Bartonellosis; Cat scratch disease

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAM; CEFACLOR; CEFALEXIN; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; NORFLOXACIN; OXACILLIN; PENICILLIN G; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; BARTONELLA BACILLIFORMIS; BARTONELLA HENSELAE; BARTONELLA QUINTANA; BARTONELLOSIS; CARRION DISEASE; CAT SCRATCH DISEASE; CHRONIC BACTEREMIA; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; META ANALYSIS; OBSERVATIONAL STUDY; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIBIOTIC TREATMENT; BACILLARY ANGIOMATOSIS; BARTONELLA BACILLIFORMIS; BARTONELLA HENSELAE; BARTONELLA QUINTANA; BARTONELLOSIS; CAT SCRATCH DISEASE;

ANTI-BACTERIAL AGENTS; BARTONELLA; BARTONELLA INFECTIONS; DOXYCYCLINE; GENTAMICINS; HUMANS; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84883776774     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.02.016     Document Type: Review

References (32)

1. Biswas S., Rolain J.M. Bartonella infection: treatment and drug resistance. Future Microbiol 2010, 5:1719-1731.
2. Blanco J.R., Raoult D. [Diseases produced by Bartonella]. Enferm Infecc Microbiol Clin 2005, 23:313-319. quiz 20.
3. Windsor J.J. Cat-scratch disease: epidemiology, aetiology and treatment. Br J Biomed Sci 2001, 58:101-110.
4. Hamilton D.H., Zangwill K.M., Hadler J.L., Cartter M.L. Cat-scratch disease-Connecticut, 1992-1993. J Infect Dis 1995, 172:570-573.
5. Brouqui P., Lascola B., Roux V., Raoult D. Chronic Bartonella quintana bacteremia in homeless patients. N Engl J Med 1999, 340:184-189.
6. Guibal F., de La Salmoniere P., Rybojad M., Hadjrabia S., Dehen L., Arlet G. High seroprevalence to Bartonella quintana in homeless patients with cutaneous parasitic infestations in downtown Paris. J Am Acad Dermatol 2001, 44:219-223.
7. Maguina C., Ugarte-Gil C., Brena Chavez P., Ordaya Espinoza E., Ventosilla Lopez P., Huarcaya Castilla E., et al. Actualización de la enfermedad de Carrió n. Revista Medica Herediana 2008, 19:19-36.
8. Chamberlin J., Laughlin L.W., Romero S., Solorzano N., Gordon S., Andre R.G., et al. Epidemiology of endemic Bartonella bacilliformis: a prospective cohort study in a Peruvian mountain valley community. J Infect Dis 2002, 186:983-990.
9. Relman D.A. Has trench fever returned?. N Engl J Med 1995, 332:463-464.
10. Maguina C., Gotuzzo E. Bartonellosis. New and old. Infect Dis Clin North Am 2000, 14:1-22. vii.
11. Relman D.A., Falkow S., LeBoit P.E., Perkocha L.A., Min K.W., Welch D.F., et al. The organism causing bacillary angiomatosis, peliosis hepatis, and fever and bacteremia in immunocompromised patients. N Engl J Med 1991, 324:1514.
12. Resto-Ruiz S., Burgess A., Anderson B.E. The role of the host immune response in pathogenesis of Bartonella henselae. DNA Cell Biol 2003, 22:431-440.
13. Ihler G.M. Bartonella bacilliformis: dangerous pathogen slowly emerging from deep background. FEMS Microbiol Lett 1996, 144:1-11.
14. Maguina C., Garcia P.J., Gotuzzo E., Cordero L., Spach D.H. Bartonellosis (Carrion's disease) in the modern era. Clin Infect Dis 2001, 33:772-779.
15. Minnick M.F., Mitchell S.J., McAllister S.J. Cell entry and the pathogenesis of Bartonella infections. Trends Microbiol 1996, 4:343-347.
16. Rolain J.M., Brouqui P., Koehler J.E., Maguina C., Dolan M.J., Raoult D. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004, 48:1921-1933.
17. Regnery R., Tappero J. Unraveling mysteries associated with cat-scratch disease, bacillary angiomatosis, and related syndromes. Emerg Infect Dis 1995, 1:16-21.
18. Mofenson L.M., Brady M.T., Danner S.P., Dominguez K.L., Hazra R., Handelsman E., et al. Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep 2009, 58:1-166.
19. Krueger J., Clement R.W. The truly false consensus effect: an ineradicable and egocentric bias in social perception. J Pers Soc Psychol 1994, 67:596-610.
20. National Institutes of Health. Common terminology criteria for adverse events (CTCAE). US Department of Health and Human Services; 2009.
21. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
22. Peters J.L., Sutton A.J., Jones D.R., Abrams K.R., Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006, 295:676-680.
23. Bass J.W., Freitas B.C., Freitas A.D., Sisler C.L., Chan D.S., Vincent J.M., et al. Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J 1998, 17:447-452.
24. Foucault C., Raoult D., Brouqui P. Randomized open trial of gentamicin and doxycycline for eradication of Bartonella quintana from blood in patients with chronic bacteremia. Antimicrob Agents Chemother 2003, 47:2204-2207.
25. Arisoy E.S., Correa A.G., Wagner M.L., Kaplan S.L. Hepatosplenic cat-scratch disease in children: selected clinical features and treatment. Clin Infect Dis 1999, 28:778-784.
26. Collio P.J. Cat-scratch disease: therapy with trimethoprim-sulfamethoxazole. Am J Dis Child 1992, 146:397-399.
27. Margileth A.M. Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature. Pediatr Infect Dis J 1992, 11:474-478.
28. Foucault C., Barrau K., Brouqui P., Raoult D. Bartonella quintana bacteremia among homeless people. Clin Infect Dis 2002, 35:684-689.
29. Plettenberg A., Lorenzen T., Burtsche B.T., Rasokat H., Kaliebe T., Albrecht H., et al. Bacillary angiomatosis in HIV-infected patients-an epidemiological and clinical study. Dermatology 2000, 201:326-331.
30. Raoult D., Fournier P.E., Vandenesch F., Mainardi J.L., Eykyn S.J., Nash J., et al. Outcome and treatment of Bartonella endocarditis. Arch Intern Med 2003, 163:226-230.
31. Rolain J.M., Maurin M., Raoult D. Bactericidal effect of antibiotics on Bartonella and Brucella spp: clinical implications. J Antimicrob Chemother 2000, 46:811-814.
32. Martin L., Vidal L., Campins A., Salva F., Riera M., Carrillo A., et al. Bartonella as a cause of blood culture-negative endocarditis. Description of five cases. Rev Esp Cardiol 2009, 62:694-697.